The International Journal of Clinical Metabolism and Diabetes is a refereed journal publishing three times a year. It is a publication of the Research Society for the Study of Diabetes in India (RSSDI), the largest body in India representing metabolic disorders and covers the area of endocrinology and diabetes. The journal follows rigorous peer review.
The journal includes research projects, review articles, systematic reviews, real-world evidence, RCTs (Randomized controlled clinical trials) and RSSDI conference proceedings.
The journal represents the transitioning of diabetology into metabolic medicine representing science as a spectrum from obesity to diabetes, its complications and comorbidities. The journal will thus extend into areas such as cardiometabolic renal hepatic and cognitive dysfunction as they impact metabolism. The journal is intended to be clinically relevant to the practising physician and scholar alike, particularly emphasising thematic reviews of real-world evidence and pragmatic clinical trials. Emerging areas of therapeutics, the impact of digital medicine, personalised medicine, and technology will find a special place in the journal.
International Journal of Clinical Metabolism and Diabetes is the official publication of the Research Society for the Study of Diabetes in India (RSSDI), the largest body in India representing metabolic disorders. The Journal is clinically oriented and focuses on including research projects, review articles, a section for young researchers' perspectives, systematic reviews, real-world evidence, RCTs (Randomized controlled clinical trials) and RSSDI conference proceedings. The journal follows a double-anonymized peer review policy.
The journal's defined mission statement is to improve patient care and outcomes through the promotion of science in alignment with the mission of RSSDI.
The journal's audience includes physicians, diabetologists, and endocrinologists and would focus on the areas of diabetes and metabolic disorders including but not limited to the following:
4. Nutrition and Lifestyle
5. Non-alcoholic Fatty Liver Disease (NAFLD)
6. Diabetic Kidney Disease (DKD)
7. Psychosocial Aspects of Diabetes
9. Multidisciplinary Care
|Krishna Seshadri||Apollo Specialty Hospital, Chennai, India|
|Samit Ghosal||Nightingale Hospital, Kolkata, India|
|Usha Ayyagari||Sr. Consultant Endocrinologist & Diabetologist, Apollo Chennai|
|Puneet Misra||All India Institute of Medical Sciences (AIIMS), India|
|Deep Datta||Cedar Superspeciality Clinics|
|Mala Dharmalingam||MS Ramaiah Medical College/ Endocrinology and Diabetes Research Center and Laboratory, Bangalore|
|JJ Mukherjee||Apollo Gleneagles|
|Nitin Kapoor||Christian Medical College, India|
|Joe George||Endodiab Clinic|
|Chitra Selvan||MS Ramaiah Medical College|
|Ashu Rastogi||Post Graduate Institute of Medical Education and Research (PGIMER)|
|Sunder Mudaliar||University of California San Diego, USA|
|Rohit Kulkarni||Harvard University|
|Ashok Balasubramaniam||Baylor College of Medicine, USA|
|Kamlesh Khunthi||University of Leicester|
|Noel Somasundaram||National Hospital of Sri Lanka|
|Sam Dagago Jack||University of Tenessee|
|Banshi Saboo||Chair SE Asia International Diabetes Federation (IDF)|
|Shashank R Joshi||Former Chair SE Asia IDF|
|Rajeev Chawla||Editor in Chief – North Delhi Diabetes Centre|
|Ashok Kumar Das||Sri Balaji Vidyapeeth Puducherry|
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site https://peerreview.sagepub.com/cmd to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of International Journal of Clinical Metabolism and Diabetes will be reviewed.
There are no fees payable to submit or publish in this Journal. Open Access options are available - see section 3.3 below.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that International Journal of Clinical Metabolism and Diabetes will consider submissions of papers that have been posted on preprint servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the Journal. If the article is accepted for publication, the author may re-use their work according to the Journal's author archiving policy.
If your paper is accepted, you must include a link on your preprint to the final version of your paper.
If you have any questions about publishing with Sage, please visit the Sage Journal Solutions Portal.
2.1 Peer review policy
2.3.1 Writing assistance
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
2.9 Research data
Before submitting your manuscript to International Journal of Clinical Metabolism and Diabetes, please ensure you have read the Aims & Scope.
International Journal of Clinical Metabolism and Diabetes invites the following types of papers:
- Original articles
- Narrative reviews
- Systematic reviews and Meta analysis
- Case Reports
- Letters to the editor
The word limit for original articles and review is 3000 excluding references and an abstract (structured format) of not more than 250 words. Editorials, perspectives and case reports should not be more than 1500 words; and letters should be restricted to 700 words.
There is no arbitrary limit on the number of references.
The Sage Author Gateway has some general advice on how to get published, plus links to further resources.
1.3.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online.
International Journal of Clinical Metabolism and Diabetes adheres to a rigorous double-anonymized reviewing policy in which the identity of both the reviewer and author are always concealed from both parties. Each manuscript is reviewed by at least two referees.
- All manuscripts are reviewed initially by the Editors and only those papers that meet the editorial standards of the journal, and fit within the aims and scope of the journal, will be sent for outside review.
- Decisions on manuscripts will be taken as rapidly as possible. Authors should expect to have the reviewer’s comments within approximately 6 weeks. In general, Editors will seek advice from two or more expert reviewers about the content and presentation of submitted articles.
All manuscripts are reviewed initially by the Editors and only those papers that meet the editorial standards of the journal, and fit within the aims and scope of the journal, will be sent for outside review.
In general, Editors will seek advice from two or more expert reviewers about the content and presentation of submitted articles. The Editor will consider the reviewers’ recommendations and assess whether a contribution should be accepted for publication subject to stipulated changes or that the author(s) should be requested to revise the manuscript substantially or that the manuscript is not yet fully developed.
Decisions on manuscripts will be taken as early as possible. Authors can expect Editorial decision within 45 days from submission.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.
2.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
International Journal of Clinical Metabolism and Diabetes requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the Sage Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of International Journal of Clinical Metabolism and Diabetes to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
2.6. Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant ethics committee or institutional review board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
International Journal of Clinical Metabolism and Diabetes endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
CONSORT Flowchart Example
PRISMA flowchart for new systematic reviews which included searches of databases and registers only
*Consider, if feasible to do so, reporting the number of records identified from each database or register searched (rather than the total number across all databases/registers).
**If automation tools were used, indicate how many records were excluded by a human and how many were excluded by automation tools.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
At Sage we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, International Journal of Clinical Metabolism and Diabetes encourages authors to share their research data in a suitable public repository subject to ethical considerations and where data is included, to add a data accessibility statement in their manuscript file. Authors should also follow data citation principles. For more information please visit the Sage Author Gateway, which includes information about Sage’s partnership with the data repository Figshare.
Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the Sage Author Gateway
International Journal of Clinical Metabolism and Diabetes and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a Sage journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the Sage Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, Sage requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Sage’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants Sage the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than Sage. In this case copyright in the work will be assigned from the author to the society. For more information please visit the Sage Author Gateway.
International Journal of Clinical Metabolism and Diabetes offers optional open access publishing via the Sage Choice programme and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. For more information on Open Access publishing options at Sage please visit Sage Open Access. For information on funding body compliance, and depositing your article in repositories, please visit Sage’s Author Archiving and Re-Use Guidelines and Publishing Policies.
The preferred format for your manuscript is Word.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit Sage’s Manuscript Submission Guidelines
Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files.
International Journal of Clinical Metabolism and Diabetes adheres to the APA reference style. View the APA guidelines to ensure your manuscript conforms to this reference style.
International Journal of Clinical Metabolism and Diabetes is hosted on Sage Track Sage, a web based online submission and peer review system. Visit https://peerreview.sagepub.com/cmd to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit Sage Track Sage.
International Journal of Clinical Metabolism and Diabetes adheres to the APA reference style. View the APA guidelines to ensure your manuscript conforms to this reference style.
As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this Journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the Sage Author Gateway.
Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the Sage Journals help page for more details, including how to cite Online First articles.
Sage provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The Sage Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the International Journal of Clinical Metabolism and Diabetes editorial office as follows:
Dr. Krishna Seshadri (Editor-in-Chief)
E-mail Id: email@example.com